8-K
Current Report
Oric Pharmaceuticals, Inc. Filed Acc 0001564590-20-028816
Executive or director change
- Item 5.02 Departure or appointment of directors or officers
From the SEC's structured data for this filing
Loading oric-8k_20200609.htm…